Bookmark
Forward
Discovery of a highly potent, functionally-selective muscarinic M1 agonist, WAY-132983 using rational drug design and receptor modelling.
A L Sabb, G M Husbands, J Tokolics, R P Stein, R P Tasse, C A Boast, J A Moyer, M Abou-Gharbia
Wyeth-Ayerst Research, Princeton, NJ 08543-8000, USA.
Bioorganic & medicinal chemistry letters 1999 Jul 19
Sizes of these terms reflect their relevance to your search.
Rational drug design utilizing a receptor homology model of the human muscarinic M1 receptor led to the discovery of the highly potent (Ki = 2 nM), efficacious, and in vivo functionally-selective M1 agonist, WAY-132983.
Citation
A L Sabb, G M Husbands, J Tokolics, R P Stein, R P Tasse, C A Boast, J A Moyer, M Abou-Gharbia.
Discovery of a highly potent, functionally-selective muscarinic M1 agonist, WAY-132983 using rational drug design and receptor modelling.
Bioorganic & medicinal chemistry letters.
1999 Jul 19;9(14):1895-900
Mesh Tags
Administration, Oral
Animals
Bridged Compounds
CHO Cells
Carbachol
Cerebral Cortex
Cognition Disorders
Computer Simulation
Cricetinae
Crystallography, X-Ray
Drug Design
Drug Evaluation, Preclinical
Humans
Macaca mulatta
Maze Learning
Models, Molecular
Muscarinic Agonists
Phosphatidylinositols
Protein Conformation
Pyrazines
Pyridines
Rats
Receptor, Muscarinic M1
Receptors, Muscarinic
Salivation
Structure-Activity Relationship
Thiadiazoles
Substances
Bridged Compounds
Muscarinic Agonists
Phosphatidylinositols
Pyrazines
Pyridines
Receptor, Muscarinic M1
Receptors, Muscarinic
Thiadiazoles
WAY 132983
xanomeline
Carbachol
PMID: 10450949
View Full Text